Ningthoujam Indrajit Singh

Mr. Ningthoujam Indrajit Singh

KIIT University, Bhubaneswar, India
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2022 in Molecules
Verified
Journal Article
Open access
PDF file
TDThangjam Davis
Thangjam Davis
NSNingthoujam Indrajit Singh
Ningthoujam Indrajit Singh
KDKhuraijam Mrinalini Devi
Khuraijam Mrinalini Devi
RMRemmei Meiguilungpou
Remmei Meiguilungpou
LKLhaineichong Khongsai
Lhaineichong Khongsai
TSTHIYAM RAMSING SINGH
THIYAM RAMSING SINGH
The use of cisplatin as a chemotherapeutic drug is impeded by the development of drug resistance. Combination therapies of a chemosensitizer for cisplatin have been studied, but with little success, and the search for an effective combination therapy is continuing. Our earlier reports have shown that Zanthoxylum armatum DC. extract enhances the apoptotic effect of cisplatin in cancer cell lines. In this study, we purified and identified the bioactive phytocompound through bio-assay-guided purification, using column chromatography and HPLC. Chemical characterization using NMR and mass spectrometry revealed the compound as planispine A, with molecular structure C25H30O6 and molecular weight, 426.16 g/mol. Planispine A was found to inhibit cancer cell proliferation in a dose-dependent manner and to sensitize the cancer cells to cisplatin-augmented apoptotic cell death, in a caspase-dependent manner. A combination of planispine A and cisplatin induced S-phase cell cycle arrest, and reduced the expression of survival proteins such as cyclin D1. Interestingly, planispine A inhibits the Fanconi anemia pathway, as shown by reduced FANCD2 foci formation and FANCD2 monoubiquitination, which revealed the molecular mechanism of chemo-sensitization of cancer cells to cisplatin. Evaluation of this combination therapy in cisplatin-resistant tumors may lead to more efficient cisplatin treatment.

9 October 2026 in Chemistry & Biodiversity
Verified
Journal Article
Open access
NSNingthoujam Indrajit Singh
Ningthoujam Indrajit Singh
SSSalam Pradeep Singh
Salam Pradeep Singh
CMChayan Mukherjee
Chayan Mukherjee
CSChingakham Brajakishor Singh
Chingakham Brajakishor Singh
In the present study, bioactive lignans from Zanthoxylum armatum fruits have been investigated for their anti‐inflammatory properties and evaluated using dendritic cell‐based immunological assays and network pharmacology. The ethyl acetate fraction was subjected to bioassay‐guided fractionation, chromatography, and HPLC to isolate pure compounds, characterised by NMR, LC‐QTOF‐MS, and single‐crystal x‐ray diffraction. Biological activities were evaluated using DPPH/ABTS radical scavenging assays, albumin denaturation and haemolysis inhibition assays, and flow cytometric analysis of IL‐12p40/70 and CD80 expression in CpG‐stimulated MuTuDC1940 dendritic cells. Sesamin exhibited the strongest antioxidant activity, while sesamin and fargesin showed notable anti‐inflammatory effects. In CpG‐stimulated MuTuDC1940 cells, sesamin reduced the proportion of IL‐12‐positive cells from 63.85% in the CpG‐treated group to 52.67%, whereas fargesin (63.23%) showed little change and eudesmin (65.88%) showed a slight increase. Nevertheless, intracellular IL‐12 MFI was significantly reduced by eudesmin, sesamin, and fargesin compared with CpG stimulation ( p < 0.01), suggesting modulation of IL‐12 expression intensity rather than a uniform reduction in the IL‐12‐positive cell population. Network pharmacology, PPI, GO, and KEGG analyses indicated involvement of PI3K–Akt, NF‐κB, JAK–STAT, toll‐like receptor, Rap1, and VEGF signalling pathways. These findings suggest these compounds may serve as potential natural therapeutics for inflammatory and immune‐mediated diseases.